Global Antidiarrhoeal Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028022 No. of Pages: 137 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Antidiarrhoeal market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.
This report studies the Antidiarrhoeal market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Antidiarrhoeal in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Mucosal Protectants
Motility Modifying Drugs
Market Snapshot, By Application
Online
Offline
Main Market Players Analyzed in this report, including:
Perrigo
Lupin Limited
Johnson and Johnson
Glenmark Pharmaceuticals
GlaxoSmithKline
The study objectives of this report are:
To study and analyze the global Antidiarrhoeal market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Antidiarrhoeal market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Antidiarrhoeal manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antidiarrhoeal market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Antidiarrhoeal submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Antidiarrhoeal are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Antidiarrhoeal Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Antidiarrhoeal Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Antidiarrhoeal
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Antidiarrhoeal Sales Channel and Distributors Analysis
3.3.1 Antidiarrhoeal Sales Channel
3.3.2 Antidiarrhoeal Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Online
3.4.2 Major Buyers in Offline
3.5 Antidiarrhoeal Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Antidiarrhoeal Type Introduction
4.1.1 Mucosal Protectants
4.1.2 Motility Modifying Drugs
4.2 Global Antidiarrhoeal Sales by Type 2016-2021
4.3 Global Antidiarrhoeal Revenue by Type 2016-2021
4.4 Global Antidiarrhoeal Price by Type 2016-2021
5 Market Segment: by Application
5.1 Antidiarrhoeal Type Introduction
5.1.1 Online
5.1.2 Offline
5.2 Global Antidiarrhoeal Sales by Application 2016-2021
5.3 Global Antidiarrhoeal Revenue by Application 2016-2021
5.4 Global Antidiarrhoeal Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Antidiarrhoeal Market by Region
6.1.1 Global Antidiarrhoeal Sales by Regions
6.1.2 Global Antidiarrhoeal Revenue by Regions
6.2 North America Antidiarrhoeal Market 2016-2021
6.3 Europe Antidiarrhoeal Market 2016-2021
6.4 Asia Pacific Antidiarrhoeal Market 2016-2021
6.5 South America Antidiarrhoeal Market 2016-2021
6.6 Middle East and Africa Antidiarrhoeal Market 2016-2021
7 North America
7.1 North America Antidiarrhoeal Market by Country 2016-2021
7.1.1 North America Antidiarrhoeal Sales by Country
7.1.2 North America Antidiarrhoeal Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Antidiarrhoeal Market by Country 2016-2021
8.1.1 Europe Antidiarrhoeal Sales by Country
8.1.2 Europe Antidiarrhoeal Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Antidiarrhoeal Market by Country 2016-2021
9.1.1 Asia Pacific Antidiarrhoeal Sales by Country
9.1.2 Asia Pacific Antidiarrhoeal Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Antidiarrhoeal Market by Country 2016-2021
10.1.1 South America Antidiarrhoeal Sales by Country
10.1.2 South America Antidiarrhoeal Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Antidiarrhoeal Market by Country 2016-2021
11.1.1 Middle East and Africa Antidiarrhoeal Sales by Country
11.1.2 Middle East and Africa Antidiarrhoeal Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Perrigo
12.1.1 Perrigo
Company Information
12.1.2 Perrigo
Antidiarrhoeal Product Portfolio, Specification and Application
12.1.3 Perrigo
Antidiarrhoeal Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Perrigo
Key Development
12.2 Lupin Limited
12.2.1 Lupin Limited
Company Information
12.2.2 Lupin Limited
Antidiarrhoeal Product Portfolio, Specification and Application
12.2.3 Lupin Limited
Antidiarrhoeal Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Lupin Limited
Key Development
12.3 Johnson and Johnson
12.3.1 Johnson and Johnson
Company Information
12.3.2 Johnson and Johnson
Antidiarrhoeal Product Portfolio, Specification and Application
12.3.3 Johnson and Johnson
Antidiarrhoeal Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Johnson and Johnson
Key Development
12.4 Glenmark Pharmaceuticals
12.4.1 Glenmark Pharmaceuticals
Company Information
12.4.2 Glenmark Pharmaceuticals
Antidiarrhoeal Product Portfolio, Specification and Application
12.4.3 Glenmark Pharmaceuticals
Antidiarrhoeal Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Glenmark Pharmaceuticals
Key Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline
Company Information
12.5.2 GlaxoSmithKline
Antidiarrhoeal Product Portfolio, Specification and Application
12.5.3 GlaxoSmithKline
Antidiarrhoeal Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 GlaxoSmithKline
Key Development
13 Global Antidiarrhoeal Market Forecast by Region by Type and by Application
13.1 Global Antidiarrhoeal Sales, Revenue Forecast 2022-2027
13.2 Global Antidiarrhoeal Forecast by Regions
13.2.1 Global Antidiarrhoeal Sales Forecast by Region 2022-2027
13.2.2 Global Antidiarrhoeal Revenue Forecast by Region 2022-2027
13.3 Global Antidiarrhoeal Forecast by Type
13.3.1 Global Antidiarrhoeal Sales Forecast by Type 2022-2027
13.3.2 Global Antidiarrhoeal Revenue Forecast by Type 2022-2027
13.3.3 Global Antidiarrhoeal Price Forecast by Type 2022-2027
13.4 Global Antidiarrhoeal Forecast by Application
13.4.1 Global Antidiarrhoeal Sales Forecast by Application 2022-2027
13.4.2 Global Antidiarrhoeal Revenue Forecast by Application 2022-2027
13.4.3 Global Antidiarrhoeal Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com